<SEC-DOCUMENT>0001654954-17-005235-index.html : 20170531 <SEC-HEADER>0001654954-17-005235.hdr.sgml : 20170531 <ACCEPTANCE-DATETIME>20170531172857 ACCESSION NUMBER: 0001654954-17-005235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170530 FILED AS OF DATE: 20170531 DATE AS OF CHANGE: 20170531 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Latkin Jed CENTRAL INDEX KEY: 0001554593 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 17882448 MAIL ADDRESS: STREET 1: 152 W. 57TH STREET STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>section16.xml <DESCRIPTION>FORM 4 LATKIN <TEXT> Document 1 - file: section16.html
Document 1 - RAW XML: section16.xml
</DOCUMENT> </SEC-DOCUMENT>